Related Experiment Video
Updated: Dec 26, 2025
09:57
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
9.0K
Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis
Giovanni Stelitano1, José Camilla Sammartino1,2, Laurent Roberto Chiarelli1
1Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, 27100 Pavia, Italy.
Molecules (Basel, Switzerland)
|March 19, 2020
Summary
Tuberculosis requires new drugs due to resistant strains. A polypharmacology approach, using single molecules targeting multiple pathways of Mycobacterium tuberculosis, offers a promising strategy for more effective treatments with fewer side effects.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Infectious Diseases
Background:
- Tuberculosis (TB) remains a critical global health issue, exacerbated by multi-drug resistant Mycobacterium tuberculosis strains.
- Existing treatments face challenges with drug resistance and potential side effects, necessitating novel therapeutic strategies.
Purpose of the Study:
- To review recent advancements in multitargeting antitubercular drug candidates.
- To explore the potential of polypharmacology as an effective strategy against tuberculosis.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of multitargeting compounds and their mechanisms of action against M. tuberculosis.
Main Results:
- Polypharmacology, involving single molecules with multiple targets, shows promise in overcoming drug resistance.
- Multitargeting agents may offer enhanced efficacy, synergistic effects, and a reduced risk of side effects compared to traditional polypharmacy.
Conclusions:
- The multitargeting approach is a rapidly developing area for novel antitubercular drug discovery.
- Promising drug candidates utilizing polypharmacology are emerging as potential solutions to combat drug-resistant tuberculosis.
More Related Videos
Related Concept Videos
01:28Pulmonary Tuberculosis V
480
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
480
01:27Combined Effects of Drugs: Synergism
6.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.6K
01:26Targets for Drug Action: Overview
9.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.8K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
01:26Pulmonary Tuberculosis IV
434
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
434